Innate immunity defines the capacity of antiviral T cells to limit persistent infection

Journal of Experimental Medicine

Volumn 207, Issue 6, 2010, Pages 1333-1343

  Andrews, Daniel M ^a,c   Estcourt, Marie J ^a,c   Andoniou, Christopher E ^a,c   Wikstrom, Matthew E ^a,c   Khong, Andrea ^a,c   Voigt, Valentina ^a,c   Fleming, Peter ^a,c   Tabarias, Hyacinth ^a,c   Hill, Geoffrey R ^d   Van Der Most, Robbert G ^b   Scalzo, Anthony A ^a,c   Smyth, Mark J ^e   Degli Esposti, Mariapia A ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c LIONS EYE INSTITUTE   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; EPITOPES; HISTOCOMPATIBILITY ANTIGENS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY A; PEPTIDES; VIRUS DISEASES;

EID: 77953524442     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20091193     Document Type: Article

References (49)

1. Allan, J.E., and G.R. Shellam. 1984. Genetic control of murine cytomegalovirus infection: virus titres in resistant and susceptible strains of mice. Arch. Virol. 81:139-150. doi:10.1007/BF01309303
2. Andoniou, C.E., S.L. van Dommelen, V. Voigt, D.M. Andrews, G. Brizard, C. Asselin-Paturel, T. Delale, K.J. Stacey, G. Trinchieri, and M.A. Degli-Esposti. 2005. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat. Immunol. 6:1011-1019. doi:10.1038/ni1244
3. Andrews, D.M., C.E. Andoniou, F. Granucci, P. Ricciardi-Castagnoli, and M.A. Degli-Esposti. 2001. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol. 2:1077-1084. doi:10.1038/ni724
4. Andrews, D.M., A.A. Scalzo, W.M. Yokoyama, M.J. Smyth, and M.A. Degli-Esposti. 2003. Functional interactions between dendritic cells and NK cells during viral infection. Nat. Immunol. 4:175-181. doi:10.1038/ni880 (Pubitemid 36193020)
5. Andrews, D.M., C.E. Andoniou, P. Fleming, M.J. Smyth, and M.A. Degli-Esposti. 2008. The early kinetics of cytomegalovirus-specific CD8+ T-cell responses are not affected by antigen load or the absence of perforin or gamma interferon. J. Virol. 82:4931-4937. doi:10.1128/JVI.02127-07
6. Appay, V., D.F. Nixon, S.M. Donahoe, G.M. Gillespie, T. Dong, A. King, G.S. Ogg, H.M. Spiegel, C. Conlon, C.A. Spina, et al. 2000. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:63-75. doi:10.1084/jem.192.1.63
7. Arase, H., E.S. Mocarski, A.E. Campbell, A.B. Hill, and L.L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science. 296:1323-1326. doi:10.1126/science.1070884 (Pubitemid 34522789)
8. Bancroft, G.J., G.R. Shellam, and J.E. Chalmer. 1981. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J. Immunol. 126:988-994.
9. Barber, G.N. 2001. Host defense, viruses and apoptosis. Cell Death Differ. 8:113-126. doi:10.1038/sj.cdd.4400823
10. Boaz, M.J., A. Waters, S. Murad, P.J. Easterbrook, and A. Vyakarnam. 2002. Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection. J. Immunol. 169:6376-6385.
11. Brown, M.G., A.O. Dokun, J.W. Heusel, H.R.C. Smith, D.L. Beckman, E.A. Blattenberger, C.E. Dubbelde, L.R. Stone, A.A. Scalzo, and W.M. Yokoyama. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science. 292:934-937. doi:10.1126/science.1060042
12. Bukowski, J.F., B.A. Woda, and R.M. Welsh. 1984. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52:119-128. (Pubitemid 14000479)
13. Cavanaugh, V.J., Y. Deng, M.P. Birkenbach, J.S. Slater, and A.E. Campbell. 2003. Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland. J. Virol. 77:1703-1717. doi:10.1128/JVI.77.3.1703-1717.2003
14. Champagne, P., G.S. Ogg, A.S. King, C. Knabenhans, K. Ellefsen, M. Nobile, V. Appay, G.P. Rizzardi, S. Fleury, M. Lipp, et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature. 410:106-111. doi:10.1038/35065118
15. D'Souza, M., A.P. Fontenot, D.G. Mack, C. Lozupone, S. Dillon, A. Meditz, C.C. Wilson, E. Connick, and B.E. Palmer. 2007. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction. J. Immunol. 179:1979-1987.
16. Daniels, K.A., G. Devora, W.C. Lai, C.L. O'Donnell, M. Bennett, and R.M. Welsh. 2001. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J. Exp. Med. 194:29-44. doi:10.1084/jem.194.1.29
17. Degli-Esposti, M.A., and M.J. Smyth. 2005. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat. Rev. Immunol. 5:112-124. doi:10.1038/nri1549
18. Del Val, M., H.J. Schlicht, H. Volkmer, M. Messerle, M.J. Reddehase, and U.H. Koszinowski. 1991. Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope. J. Virol. 65:3641-3646.
19. Dokun, A.O., S. Kim, H.R.C. Smith, H.S.P. Kang, D.T. Chu, and W.M. Yokoyama. 2001. Specific and nonspecific NK cell activation during virus infection. Nat. Immunol. 2:951-956. doi:10.1038/ni714 (Pubitemid 32976168)
20. Gamadia, L.E., E.B. Remmerswaal, J.F. Weel, F. Bemelman, R.A. van Lier, and I.J. Ten Berge. 2003. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood. 101:2686-2692. doi: 10.1182/blood-2002-08-2502
21. Harari, A., S. Petitpierre, F. Vallelian, and G. Pantaleo. 2004. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood. 103:966-972. doi:10.1182/blood-2003-04-1203 (Pubitemid 38129558)
22. Hasan, M., A. Krmpotic, Z. Ruzsics, I. Bubic, T. Lenac, A. Halenius, A. Loewendorf, M. Messerle, H. Hengel, S. Jonjic, and U.H. Koszinowski. 2005. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. J. Virol. 79:2920-2930. doi:10.1128/JVI.79.5.2920-2930.2005 (Pubitemid 40270570)
23. Hsieh, S.M., S.C. Pan, C.C. Hung, H.C. Tsai, M.Y. Chen, and S.C. Chang. 2001. Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. J. Infect. Dis. 184:1386-1391. doi:10.1086/324419
24. Jonjic, S., W. Mutter, F. Weiland, M.J. Reddehase, and U.H. Koszinowski. 1989. Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes. J. Exp. Med. 169:1199-1212. doi:10.1084/jem.169.4.1199 (Pubitemid 19104957)
25. Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, et al. 2002. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity. 17:211-220. doi:10.1016/S1074-7613(02)00365- 5
26. Kaufmann, D.E., D.G. Kavanagh, F. Pereyra, J.J. Zaunders, E.W. Mackey, T. Miura, S. Palmer, M. Brockman, A. Rathod, A. Piechocka-Trocha, et al. 2007. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat. Immunol. 8:1246-1254. doi:10.1038/ni1515
27. Krebs, P., M.J. Barnes, K. Lampe, K. Whitley, K.S. Bahjat, B. Beutler, E. Janssen, and K. Hoebe. 2009. NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses. Blood. 113:6593-6602. doi:10.1182/blood-2009-01-201467
28. Krmpotic, A., M. Hasan, A. Loewendorf, T. Saulig, A. Halenius, T. Lenac, B. Polic, I. Bubic, A. Kriegeskorte, E. Pernjak-Pugel, et al. 2005. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. J. Exp. Med. 201:211-220. doi:10.1084/jem.20041617
29. Lee, S.H., S. Girard, D. Macina, M. Busà, A. Zafer, A. Belouchi, P. Gros, and S.M. Vidal. 2001. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28:42-45. doi:10.1038/88247
30. Lodoen, M., K. Ogasawara, J.A. Hamerman, H. Arase, J.P. Houchins, E.S. Mocarski, and L.L. Lanier. 2003. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 197:1245-1253. doi:10.1084/jem.20021973
31. Lodoen, M.B., G. Abenes, S. Umamoto, J.P. Houchins, F. Liu, and L.L. Lanier. 2004. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. J. Exp. Med. 200:1075-1081. doi:10.1084/jem.20040583
32. Lucin, P., I. Pavic, B. Polic, S. Jonjic, and U.H. Koszinowski. 1992. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J. Virol. 66:1977-1984.
33. Martin, M.P., Y. Qi, X. Gao, E. Yamada, J.N. Martin, F. Pereyra, S. Colombo, E.E. Brown, W.L. Shupert, J. Phair, et al. 2007. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39:733-740. doi:10.1038/ng2035
34. Mathys, S., T. Schroeder, J. Ellwart, U.H. Koszinowski, M. Messerle, and U. Just. 2003. Dendritic cells under influence of mouse cytomegalovirus have a physiologic dual role: to initiate and to restrict T cell activation. J. Infect. Dis. 187:988-999. doi:10.1086/368094 (Pubitemid 36337912)
35. Matloubian, M., R.J. Concepcion, and R. Ahmed. 1994. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 68:8056-8063.
36. Pitcher, C.J., C. Quittner, D.M. Peterson, M. Connors, R.A. Koup, V.C. Maino, and L.J. Picker. 1999. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5:518-525. doi:10.1038/8400
37. Robbins, S.H., G. Bessou, A. Cornillon, N. Zucchini, B. Rupp, Z. Ruzsics, T. Sacher, E. Tomasello, E. Vivier, U.H. Koszinowski, and M. Dalod. 2007. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog. 3:e123. doi:10.1371/journal.ppat.0030123
38. Rosenberg, E.S., J.M. Billingsley, A.M. Caliendo, S.L. Boswell, P.E. Sax, S.A. Kalams, and B.D. Walker. 1997. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science. 278:1447-1450. doi:10.1126/science.278.5342.1447
39. Rouvio, O., T. Dvorkin, H. Amir-Kroll, D. Atias, I.R. Cohen, B. Rager- Zisman, and A. Porgador. 2005. Self HSP60 peptide serves as an immunogenic carrier for a CTL epitope against persistence of murine cytomegalovirus in the salivary gland. Vaccine. 23:3508-3518. doi: 10.1016/j.vaccine.2005.02.002 (Pubitemid 40602785)
40. Scalzo, A.A., N.A. Fitzgerald, A. Simmons, A.B. La Vista, and G.R. Shellam. 1990. Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J. Exp. Med. 171:1469-1483. doi: 10.1084/jem.171.5. 1469
41. Scalzo, A.A., N.A. Fitzgerald, C.R. Wallace, A.E. Gibbons, Y.C. Smart, R.C. Burton, and G.R. Shellam. 1992. The effect of the Cmv-1 resistance gene, which is linked to the natural killer cell gene complex, is mediated by natural killer cells. J. Immunol. 149:581-589.
42. Scalzo, A.A., M.G. Brown, D.T. Chu, J.W. Heusel, W.M. Yokoyama, and C.A. Forbes. 1999. Development of intra-natural killer complex (NKC) recombinant and congenic mouse strains for mapping and functional analysis of NK cell regulatory loci. Immunogenetics. 49:238-241. doi:10.1007/s002510050486
43. Semmo, N., and P. Klenerman. 2007. CD4+ T cell responses in hepatitis C virus infection. World J. Gastroenterol. 13:4831-4838. (Pubitemid 47496748)
44. Shellam, G.R., J.E. Allan, J.M. Papadimitriou, and G.J. Bancroft. 1981. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc. Natl. Acad. Sci. USA. 78:5104-5108. doi:10.1073/pnas.78.8.5104
45. Smith, H.R., J.W. Heusel, I.K. Mehta, S. Kim, B.G. Dorner, O.V. Naidenko, K. Iizuka, H. Furukawa, D.L. Beckman, J.T. Pingel, et al. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA. 99:8826-8831.
46. Steinman, R.M., and M.D. Witmer. 1978. Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. USA. 75:5132-5136. doi:10.1073/pnas.75.10.5132
47. Su, H.C., K.B. Nguyen, T.P. Salazar-Mather, M.C. Ruzek, M.Y. Dalod, and C.A. Biron. 2001. NK cell functions restrain T cell responses during viral infections. Eur. J. Immunol. 31:3048-3055. doi:10.1002/1521-4141(2001010)31: 10〈3048::AID-IMMU3048〉3.0.CO;2-1
48. Voigt, V., C.A. Forbes, J.N. Tonkin, M.A. Degli-Esposti, H.R. Smith, W.M. Yokoyama, and A.A. Scalzo. 2003. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. Proc. Natl. Acad. Sci. USA. 100:13483-13488. doi:10.1073/pnas.2233572100
49. Volkmer, H., C. Bertholet, S. Jonjić, R. Wittek, and U.H. Koszinowski. 1987. Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate-early protein pp89 expressed by recombinant vaccinia virus. J. Exp. Med. 166:668-677. doi:10.1084/jem.166.3.668